General Information of the Compound
| Compound ID |
CP0859455
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N2-(2-aminophenyl)-N5-(4-(3-ethynylphenylamino)quinazolin-7-yl)pyridine-2,5-dicarboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H21N7O2
|
||||||||||||||||||
| Molecular Weight |
499.534
|
||||||||||||||||||
| Canonical SMILES |
C#Cc1cccc(Nc2ncnc3cc(NC(=O)c4ccc(C(=O)Nc5ccccc5N)nc4)ccc23)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H21N7O2/c1-2-18-6-5-7-20(14-18)34-27-22-12-11-21(15-26(22)32-17-33-27)35-28(37)19-10-13-25(31-16-19)29(38)36-24-9-4-3-8-23(24)30/h1,3-17H,30H2,(H,35,37)(H,36,38)(H,32,33,34)
Show/Hide
|
||||||||||||||||||
| InChIKey |
WHXCYVUSVRUZHI-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00991, Histone deacetylase 1
Protein ID: PT00995, Histone deacetylase 3
Protein ID: PT01213, Histone deacetylase 6
Protein ID: PT01499, Histone deacetylase 8
Cell Viability or Cytotoxicity Assay
| Cell Line ID | Cell Line Name | Cell Line Organism | |
| CL000084 | SK-OV-3 | Homo sapiens (Human) | 1 |
| 1 |
IC50 > 50000 nM
|
TI
LI
LO
TS
|
|
|---|---|---|---|